DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,009,521 | -30.1% | 335,884 | -12.2% | 0.04% | -31.4% |
Q2 2023 | $4,303,980 | -6.1% | 382,576 | -42.6% | 0.05% | -28.2% |
Q2 2022 | $4,582,000 | -41.5% | 666,997 | -18.0% | 0.07% | -44.1% |
Q1 2022 | $7,839,000 | +28.1% | 813,139 | +58.0% | 0.13% | +44.3% |
Q4 2021 | $6,119,000 | +74.3% | 514,601 | +138.0% | 0.09% | +54.4% |
Q3 2021 | $3,511,000 | -25.0% | 216,201 | -2.8% | 0.06% | -34.5% |
Q2 2021 | $4,679,000 | -21.2% | 222,374 | -41.9% | 0.09% | -34.1% |
Q1 2021 | $5,940,000 | -42.4% | 382,493 | -22.1% | 0.13% | -51.6% |
Q4 2020 | $10,311,000 | +91.4% | 490,986 | +84.0% | 0.27% | +54.2% |
Q3 2020 | $5,387,000 | – | 266,799 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $28,535,000 | 16.60% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $47,731,000 | 16.31% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $86,132,000 | 10.89% |
Logos Global Management LP | 2,734,392 | $26,360,000 | 3.42% |
Deep Track Capital, LP | 3,500,000 | $33,740,000 | 2.16% |
Octagon Capital Advisors LP | 525,284 | $5,064,000 | 1.10% |
HighVista Strategies LLC | 168,691 | $1,626,000 | 1.03% |
Monashee Investment Management LLC | 279,704 | $2,696,000 | 0.78% |
COMMODORE CAPITAL LP | 305,125 | $2,941,000 | 0.66% |
RA Capital Management | 2,805,045 | $27,041,000 | 0.59% |